Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

DarioHealth Corp. (DRIO) had Revenue of $27.04M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$27.04M
Net Income	$-40.98M
Cost of Goods Sold	$13.77M
Gross Profit	$13.27M
Operating Expenses	$84.78M
Operating Income	$-57.74M
Non-Operating Income/Expense	$13.14M
Pre-Tax Income	$-44.60M
Normalized Pre-Tax Income	$-44.60M
Income after Taxes	$-42.75M
Income from Continuous Operations	$-42.75M
Consolidated Net Income/Loss	$-42.75M
Normalized Income after Taxes	$-42.75M
EBIT	$-57.74M
EBITDA	$-50.32M
Weighted-Average Shares Outstanding (Basic)	49.04M
Weighted-Average Shares Outstanding (Diluted)	49.04M
Earnings per Share (EPS) (Basic)	$-0.61
Earnings per Share (EPS) (Diluted)	$-0.61
Balance Sheet Financials
Current Assets	$40.53M
Property, Plant, and Equipment	$0.71M
Long-Term Assets	$78.36M
Total Assets	$118.88M
Current Liabilities	$16.64M
Long-Term Debt	$23.47M
Long-Term Liabilities	$30.23M
Total Liabilities	$46.87M
Common Equity	$72.02M
Tangible Shareholders Equity	$-4.17M
Shareholders Equity	$72.02M
Common Shares Outstanding	38.39M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-38.56M
Cash Flow from Investing Activities	$-8.93M
Cash Flow from Financial Activities	$38.53M
Beginning Cash	$36.80M
End Cash	$27.76M
Increase/Decrease in Cash	$-9.03M
Stock-Based Compensation	$15.80M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.44
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.25
Debt to Equity Ratio	0.40
Gross Margin	49.06%
Operating Margin	-213.55%
EBIT Margin	-213.55%
EBITDA Margin	-186.08%
Pre-Tax Profit Margin	-164.94%
Profit Margin	-151.56%
Free Cash Flow	$-38.70M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.23
Inventory Turnover	2.90
Receiveable Turnover	3.79
Days Sales in Receivables	96.38
Return on Equity	-59.36%
Return on Tangible Equity	1025.11%
Return on Assets	-35.96%
Return on Investments	-44.77%
Book Value Per Share	$1.88
Free Cash Flow per Share	$-0.79
Operating Cash Flow per Share	$-0.79

Data from Zacks Investment Research, Inc.